000 01222 a2200361 4500
005 20250514022615.0
264 0 _c20020306
008 200203s 0 0 eng d
022 _a0006-4971
024 7 _a10.1182/blood.v99.3.759
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTallman, Martin S
245 0 0 _aAcute promyelocytic leukemia: evolving therapeutic strategies.
_h[electronic resource]
260 _bBlood
_cFeb 2002
300 _a759-67 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aArsenic Trioxide
650 0 4 _aArsenicals
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLeukemia, Promyelocytic, Acute
_xdrug therapy
650 0 4 _aOxides
_xtherapeutic use
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRemission Induction
650 0 4 _aTretinoin
_xtherapeutic use
700 1 _aNabhan, Chadi
700 1 _aFeusner, James H
700 1 _aRowe, Jacob M
773 0 _tBlood
_gvol. 99
_gno. 3
_gp. 759-67
856 4 0 _uhttps://doi.org/10.1182/blood.v99.3.759
_zAvailable from publisher's website
999 _c11717654
_d11717654